Holen Sie sich die Stockscreener-App
70.23
0.67%
0.47
Handel nachbörslich:
70.22
-0.01
-0.01%
Schlusskurs vom Vortag:
$69.76
Offen:
$70.25
24-Stunden-Volumen:
2.26M
Relative Volume:
0.64
Marktkapitalisierung:
$31.72B
Einnahmen:
$20.98B
Nettoeinkommen (Verlust:
$1.98B
KGV:
16.81
EPS:
4.177
Netto-Cashflow:
$1.52B
1W Leistung:
+2.09%
1M Leistung:
+9.51%
6M Leistung:
-5.29%
1J Leistung:
-6.96%
1-Tages-Spanne:
$69.63
$71.02
1-Wochen-Bereich:
$67.66
$71.32
52-Wochen-Spanne:
$58.75
$89.77
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Firmenname
Ge Healthcare Technologies Inc
Sektor
Branche
Telefon
833-735-1139
Adresse
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
70.23 | 31.72B | 20.98B | 1.98B | 1.52B | 4.177 |
ABT
Abbott Laboratories
|
102.45 | 177.28B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.63 | 121.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
304.40 | 116.76B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.58 | 66.06B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.29 | 50.89B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-07 | Eingeleitet | Barclays | Overweight |
| 2026-09-22 | Eingeleitet | Needham | Buy |
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2026-06-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-05-21 | Hochstufung | UBS | Sell → Neutral |
| 2026-04-30 | Herabstufung | Goldman | Buy → Neutral |
| 2026-01-15 | Herabstufung | UBS | Neutral → Sell |
| 2025-10-13 | Eingeleitet | Barclays | Equal Weight |
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-05 | Hochstufung | UBS | Sell → Neutral |
| 2025-03-11 | Hochstufung | Goldman | Neutral → Buy |
| 2025-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-26 | Herabstufung | UBS | Neutral → Sell |
| 2024-09-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-06 | Eingeleitet | Stifel | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-02-15 | Eingeleitet | HSBC Securities | Buy |
| 2024-02-12 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-30 | Eingeleitet | Jefferies | Hold |
| 2023-11-27 | Herabstufung | UBS | Neutral → Sell |
| 2023-09-19 | Eingeleitet | Citigroup | Buy |
| 2023-08-25 | Eingeleitet | Argus | Buy |
| 2023-08-16 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | BofA Securities | Neutral |
| 2023-06-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-26 | Eingeleitet | UBS | Neutral |
| 2023-04-19 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-10 | Eingeleitet | BTIG Research | Neutral |
| 2023-03-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-02-17 | Eingeleitet | Mizuho | Buy |
| 2023-01-19 | Eingeleitet | Redburn | Buy |
Alle ansehen
Ge Healthcare Technologies Inc Aktie (GEHC) Neueste Nachrichten
GE HealthCare Technologies Inc. Common Stock (GEHC) Financial Statements - Pluang
Vaso Stock Surges 149% in a Year: What's Behind the Rally? - Zacks Investment Research
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum? - Zacks Investment Research
Digital X-ray MarketGlobal and Regional Analysis and Forecast, 2026-2036 | Mobile Imaging, AI Workflows, and Detector Innovation Drive Growth to $9.90 Billion - GlobeNewswire Inc.
Global Mobile X-ray Systems Market Analysis and Forecast, 2026-2036 | AI-Enabled Digital Imaging and Asia-Pacific Growth Drive a $4.00 Billion Market by 2036 - GlobeNewswire Inc.
Global Mobile C-Arm Market Analysis and Forecast, 2026-2036 | Market to Reach $3.71 Billion as Minimally Invasive Surgery, AI, and 3D Imaging Drive 5.35% CAGR - GlobeNewswire Inc.
Healthcare: Stocks Had a Great Q3, as Defensive Nature and Steady Innovation Drew Interest - Morningstar
Marjorie Taylor Greene Stock Trades and Disclosures - TechGraph
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
General Electric (GE) | History, Acquisitions, Products, & Facts - Britannica
GE HealthCare stock pre-market at EUR 57.22: minus 0.10 percent - ad-hoc-news.de
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - GlobeNewswire Inc.
GEHC vs. SYK: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
GE HealthCare Technologies (NasdaqGS:GEHC) Stock Forecast & Analyst Predictions - Simply Wall Street
GE HealthCare (GEHC) Upgraded to Buy: Here's Why - Zacks Investment Research
GE HealthCare stock pre-market at EUR 58.59: minus 0.02 percent - AD HOC NEWS
GE HealthCare Technologies (GEHC) Stock Price, News & Analysis - Stock Titan
GE HealthCare Technologies Inc. (GEHC) Stock Price, News, Quote & History - Yahoo! Finance Canada
GE HealthCare announces cash dividend increase for third quarter of 2026 - Voice of Alexandria
GE HealthCare announces cash dividend increase for third quarter of 2026 - Yahoo Finance
AT&T CFO to join GE HealthCare (Nasdaq: GEHC) board in 2027 - Stock Titan
GE HealthCare Technologies Inc.Common Stock (NQ: GEHC - The Chronicle-Journal
GEHC Stock Price Today - CoinDesk
GE HealthCare (GEHC) grants CFO options and 75K RSUs - Stock Titan
GE HealthCare CFO William K. Grogan Awarded RSUs and Stock Options on September 14, 2026 - Kalkine Media
GE HealthCare is said to near $1B Sofie Biosciences deal (GEHC:NASDAQ) - Seeking Alpha
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - whbl.com
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - WTVB
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports - Reuters
GE HealthCare stock holds near $64 after upbeat July results - ad-hoc-news.de
GE HealthCare, Leo Cancer Care to Collaborate on Imaging, Radiation Therapy Workflows - Imaging Technology News
Is GE HealthCare Stock Underperforming the Nasdaq? - inkl
GE HealthCare and RSNA bring leading cancer imaging expertise to Africa to improve access to cancer care - Zawya
Image Guided Therapy Becomes First Office-Based Lab to Install GE HealthCare's Allia(TM) Moveo - Yahoo Finance
Enterprise Imaging Solutions Market Set to Hit USD 6.69 Billion by 2035, Growing at a CAGR of 11.18%SNS Insider - GlobeNewswire Inc.
GE HealthCare Technologies Inc. stock falls Thursday, underperforms market - MarketWatch
GE HealthCare stock slips as StarGuide GX clearance and Wells Fargo outlook shape sentiment - ad-hoc-news.de
GE HealthCare stock heads into the open after a September 9 slide - ad-hoc-news.de
GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market - MarketWatch
GE HealthCare at Wells Fargo conference: backlog and margins build By Investing.com - Investing.com Nigeria
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance - Yahoo Finance
GE HealthCare at Wells Fargo conference: backlog and margins build By Investing.com - Investing.com India
Transcript : GE HealthCare Technologies Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 10 - marketscreener.com
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors? - The Motley Fool
GE HealthCare's StarGuide GX 4D SPECT/CT Now FDA 510(k) Pending - Imaging Technology News
GE HealthCare aims to advance a new era in theranostics with Sta - GuruFocus
A Look at GE HealthCare Technologies Inc (GEHC) After 3.0% Decli - GuruFocus
GE HealthCare Technologies Inc. stock falls Tuesday, underperforms market - MarketWatch
GE HealthCare Technologies Corporate Secretary Jimenez Frank R Forfeits 1,480 Shares at $70.56 on September 3, 2026 - Kalkine Media
Vaso Gains More Than 65% in Three Months: What's Driving the Stock? - Zacks Investment Research
Finanzdaten der Ge Healthcare Technologies Inc-Aktie (GEHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ge Healthcare Technologies Inc-Aktie (GEHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hochman Rodney F | Director |
May 12 '26 |
Buy |
62.03 |
1,618 |
100,365 |
1,618 |
| Yang Watkin Phoebe L. | Director |
May 08 '26 |
Buy |
63.01 |
1,000 |
63,006 |
13,702 |
| Stromberg William J | Director |
May 06 '26 |
Buy |
61.69 |
1,000 |
61,689 |
15,330 |
| CULP H LAWRENCE JR | Director |
May 06 '26 |
Buy |
61.88 |
80,805 |
5,000,076 |
151,207 |
| SACCARO JAMES | Chief Financial Officer |
May 01 '26 |
Buy |
60.60 |
3,310 |
200,585 |
87,471 |
| Arduini Peter J | President and CEO |
Apr 30 '26 |
Buy |
59.92 |
4,169 |
249,827 |
259,424 |
| Jimenez Frank R | GC & Corporate Secretary |
Apr 30 '26 |
Buy |
60.45 |
1,750 |
105,788 |
93,932 |
| Kenneth Stacherski | Former Officer |
Nov 24 '25 |
Proposed Sale |
77.00 |
4,585 |
353,045 |
0 |
| Kenneth Stacherski | Former Officer |
Oct 27 '25 |
Proposed Sale |
78.95 |
4,585 |
361,993 |
0 |
0.28%
1.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):